置顶推文

Excited to publish our #FirstInMan phase 1 study using IR800-IAB2M (near infrared #PSMA minibody) dosing and toxicity in n=23 men undergoing #RARP +/- #ePLND
#ProstateCancer #PrecisionSurgery
@NDSurgicalSci @LambAlastair
@LabBryant
link.springer.com/article/10.100…
English




















































